Scarica l'app Stockscreener
5.55
0.00%
0.00
Precedente Chiudi:
$5.55
Aprire:
$5.55
Volume 24 ore:
107.50K
Relative Volume:
1.18
Capitalizzazione di mercato:
$115.94M
Reddito:
$79.89M
Utile/perdita netta:
$-12.35M
Rapporto P/E:
-2.5227
EPS:
-2.2
Flusso di cassa netto:
$32.92M
1 W Prestazione:
+6.12%
1M Prestazione:
-3.65%
6M Prestazione:
+54.17%
1 anno Prestazione:
+11.22%
Intervallo 1D:
$5.30
$5.69
Intervallo di 1 settimana:
$5.05
$5.88
Portata 52W:
$2.85
$8.11
Journey Medical Corp Stock (DERM) Company Profile
Nome
Journey Medical Corp
Settore
Telefono
480-434-6670
Indirizzo
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Confronta DERM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
5.55 | 115.94M | 79.89M | -12.35M | 32.92M | -2.20 |
|
ZTS
Zoetis Inc
|
176.74 | 80.59B | 9.15B | 2.43B | 2.31B | 4.92 |
|
HLN
Haleon Plc Adr
|
9.72 | 44.17B | 14.26B | 1.55B | 0 | 0.3327 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.57 | 42.61B | 30.27B | 1.93B | 3.45B | 0.444 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.57 | 18.77B | 16.77B | -959.00M | 1.37B | -2.00 |
|
VTRS
Viatris Inc
|
13.22 | 15.73B | 15.05B | -883.30M | 1.89B | 1.53 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-22 | Iniziato | Rodman & Renshaw | Buy |
| 2024-06-28 | Ripresa | ROTH MKM | Buy |
| 2021-12-07 | Iniziato | B. Riley Securities | Buy |
Journey Medical Corp Borsa (DERM) Ultime notizie
Women of Influence: Erica Conroy's journey from the lab to the C-SuiteColumbus Business First - The Business Journals
FY2024 EPS Estimate for Journey Medical Decreased by Analyst - MarketBeat
FY2024 EPS Estimates for Journey Medical Boosted by B. Riley - MarketBeat
Showcasing the Journey of Researchers and Entrepreneurs at UP Manila’s Salinlohiya 2024 - University of the Philippines Manila
NY AI medical company wins global health tech competition at Scientific Sessions 2024 - American Heart Association
Journey Medical Co. (NASDAQ:DERM) Short Interest Down 20.7% in October - MarketBeat
Despite Journey Medical's Pullback, Insiders Still Gained US$118k - Yahoo Finance
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - Yahoo Finance
Topgolf Callaway Q3 Earnings & Revenues Top Estimates, Fall Y/Y - Yahoo Finance
Journey Medical Corp (DERM) Q3 2024 Earnings: Revenue Hits $14.6M, EPS Loss of $0.12 Beats Estimates - GuruFocus.com
Journey Medical earnings beat by $0.05, revenue topped estimates - Investing.com
Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Runway Growth Finance Corp. (RWAY) Q3 Earnings and Revenues Lag Estimates - Yahoo Finance
Earnings Flash (DERM) JOURNEY MEDICAL CORPORATION Reports Q3 Revenue $14.6M - Marketscreener.com
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - Yahoo Finance
Lost emperor penguin recovering after record journey across Southern Ocean - ABC News
Best travel insurance companies in 2024 - USA TODAY
FY2024 EPS Estimates for Journey Medical Raised by Analyst - MarketBeat
Q3 EPS Estimates for Journey Medical Reduced by Roth Capital - Defense World
FDA approves Journey Medical’s rosacea treatment Emrosi - Yahoo Finance
Journey gets FDA okay for Emrosi, releases preliminary Q3 earnings report (NASDAQ:DERM) - Seeking Alpha
US FDA approves Journey Medical's drug for long-term skin condition - Reuters
Journey Medical gains as US FDA approves skin condition drug - XM
Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock? - Yahoo Finance
Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea - Yahoo Finance
mWell says users gain access to 26 MPH hospitals - BusinessWorld Online
Seven PDUFA dates on FDA’s November calendar - BioCentury
Nahdi continues the growth journey with 9.0% yoy revenue increase and meeting the profitabilty guidance - ZAWYA
Biotech Stocks Facing FDA Decision In November 2024 - RTTNews
Journey Medical Co. (NASDAQ:DERM) Short Interest Update - MarketBeat
Pixee Medical Inc. Announces Josh Hagel Appointed Vice President of Sales, US - OrthoSpineNews
The Nugget Trap (RWA) Token Offering NGTG$$ commences trading - ForexTV.com
Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference - The Manila Times
Sonoma Pharmaceuticals (SNOA) Surges Amid Positive Analyst Ratin - GuruFocus.com
Her billionaire marriage broke up. Her VP campaign fizzled. Now she’s a Trump-world star. - The Washington Post
GE HealthCare announces CareIntellect for Oncology, harnessing AI to give clinicians an easy way to see the patient journey in a single view - Yahoo Finance
Live Webinar | Overcoming SASE Adoption Journey Challenges for USA Inc. - BankInfoSecurity.com
Sam Champion opens up about cancer journey - Good Morning America
SWK Holdings Provides Portfolio Update - AccessWire
Tevogen Bio Thanks Warren Township for Proclamation Honoring CEO Dr. Ryan Saadi, Nobel Peace Prize Nomination, and the Company's Mission to Address Health Inequality - The Manila Times
Will It Be A Smooth Sailing For Journey Medical's Rosacea Drug At The FDA? - RTTNews
Journey Medical Co. (NASDAQ:DERM) Sees Large Increase in Short Interest - MarketBeat
The rather unusual jet at Dunedin Airport and its epic journey here - Stuff
GE HealthCare - linkedin
Microsoft expands AI capabilities to shape a healthier future - Microsoft
Baird Medical Lists in the U.S. on the Nasdaq Exchange - Yahoo Finance
SWK Holdings announces board member resignation - Investing.com
Journey Medical Corp Azioni (DERM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.83%
1.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):